Neural Monitoring of the Superior Laryngeal Nerve in Thyroid Surgery
Launched by THE ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST · Mar 16, 2015
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Thyroid surgery can result in change in the voice. This is because two nerves controlling the voice quality are situated very close anatomically to the thyroid gland and are at risk of damage during the surgery. One of the nerves that is called the recurrent laryngeal nerve controls the movements of the voice cords and is more readily identifiable and its injury is also detected easily by direct examination of the voice box as reduced/absent movement of the voice cord. It gets damaged in upto 1% of thyroid surgeries. The other nerve that is of interest to our study is called the superior la...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing diagnostic hemithyroidectomies (thyroid nodules 5 cm or less).
- • age 18 and over
- • able to provide informed consent
- Exclusion Criteria:
- • Patients who develop a recurrent laryngeal nerve palsy following surgery will be excluded from the study.
- • Patients who withdraw consent during or after study
- • Patients with pre-existing laryngeal pathology like reinkes edema, vocal cord nodules, laryngeal inflammation, previous laryngeal surgery etc
- • Pregnant women (confirmed by history and routine pregnancy test)
- • Those unable to give informed consent
- • Previous major neck surgery such as neck dissections, laryngeal surgery, carotid endarterectomies, parathyroid and thyroid surgery.
About The Royal Wolverhampton Hospitals Nhs Trust
The Royal Wolverhampton Hospitals NHS Trust is a leading healthcare provider in the West Midlands, dedicated to delivering high-quality patient care and advancing medical research through clinical trials. As a prominent NHS trust, it encompasses a range of specialized services across multiple hospitals, focusing on innovation and evidence-based practices. The Trust actively engages in clinical research to enhance treatment options and improve patient outcomes, fostering collaboration among healthcare professionals, researchers, and academic institutions. Committed to patient safety and ethical standards, the Royal Wolverhampton Hospitals NHS Trust plays a pivotal role in advancing healthcare through rigorous clinical trials and research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wolverhampton, West Midlands, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials